BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24372249)

  • 1. Update on the development of TB Vaccines.
    Zenteno-Cuevas R
    Curr Pharm Biotechnol; 2013; 14(11):940-6. PubMed ID: 24372249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.
    Mascart F; Locht C
    Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TB vaccine development: where are we and why is it so difficult?
    Wilkie ME; McShane H
    Thorax; 2015 Mar; 70(3):299-301. PubMed ID: 25432943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successes and failures in human tuberculosis vaccine development.
    Zenteno-Cuevas R
    Expert Opin Biol Ther; 2017 Dec; 17(12):1481-1491. PubMed ID: 28927311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis: vaccine and drug development.
    Mitsuyama M; McMurray DN
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S10-3. PubMed ID: 17616481
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel vaccination strategies and approaches against human tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for TB: Lessons from the Past Translating into Future Potentials.
    Tye GJ; Lew MH; Choong YS; Lim TS; Sarmiento ME; Acosta A; Norazmi MN
    J Immunol Res; 2015; 2015():916780. PubMed ID: 26146643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico design of Mycobacterium tuberculosis epitope ensemble vaccines.
    Shah P; Mistry J; Reche PA; Gatherer D; Flower DR
    Mol Immunol; 2018 May; 97():56-62. PubMed ID: 29567319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards new tuberculosis vaccines.
    Svenson S; Källenius G; Pawlowski A; Hamasur B
    Hum Vaccin; 2010 Apr; 6(4):309-17. PubMed ID: 20372087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2016 Oct; 84(4):204-10. PubMed ID: 27454335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
    Delogu G; Provvedi R; Sali M; Manganelli R
    Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.